Hopp til innhold

Valgte elementer er lagt i handlekurven

Gå til handlekurv

Prosjekt

Bedret barnevaksinasjon og beredskap mot sesong og pandemisk influensa: betydning av cellulær immunitet - prosjektbeskrivelse

Publisert


The project aims at assessing the prevalence of past pneumococcal infections and influenza in rural and urban areas of Ethiopia with use of techniques to determine cellular immune protection against new influenza strains.


  • Start

    02.01.2013

  • Slutt

    30.12.2016

  • Status

    Avsluttet

  • Godkjenninger

    Regional committees for medical and health research ethics

  • Prosjekteier/ prosjektansvarlig

    Norwegian Institute of Public Health

  • Prosjektleder

    Siri Mjaaland

Har du funnet en feil?

Sammendrag

Since influenza may pave the way for pneumococcal infections, a cheap influenza vaccine might be a better choice than conjugated pneumococcal vaccines to protect infants and children in low-income countries against lethal pneumonia. The project aims at assessing the prevalence of past pneumococcal infections and influenza in rural and urban areas of Ethiopia with use of techniques to determine cellular immune protection against new influenza strains. The same techniques will be used to evaluate the effect on infants and children in Norway by vaccinating their mothers against pandemic influenza during pregnancy, and by a set of vaccine studies against influenza in adult volunteers, e.g. a nasal whole virus vaccine, a conventional split vaccine, a pandemic H1N1 vaccine, and two pandemic avian vaccines. Along with studies from Bangladesh, using a nasal live attenuated virus vaccine, the results may help defining formulations for universal vaccines against influenza.
Se fullstendig prosjektbeskrivelse på Cristin for mer informasjon om resultater, deltakere, kontakter med mer

Prosjektdeltakere

Prosjektleder

Siri Mjaaland, Norwegian Institute of Public Health